Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
Royal Marsden NHS Foundation Trust
Conjupro Biotherapeutics, Inc.
University of Chicago
University of Erlangen-Nürnberg Medical School
Sotio Biotech Inc.
The First Affiliated Hospital of Xiamen University
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
Pfizer
M.D. Anderson Cancer Center
Centre Oscar Lambret
Centre Oscar Lambret
Grupo Espanol de Tumores Neuroendocrinos
Hoffmann-La Roche
Genmab
Insel Gruppe AG, University Hospital Bern
Luzerner Kantonsspital
University of Washington
Pfizer
Pfizer
EMD Serono
Novartis
MacroGenics
University of Wisconsin, Madison
Flamingo Therapeutics NV
Nantes University Hospital
M.D. Anderson Cancer Center
Takeda